Y. Okada et al., Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship, CHEM PHARM, 48(12), 2000, pp. 1964-1972
Based on structure-activity relationship studies, we designed and synthesiz
ed plasmin (PL) and plasma kallikrein (PK) inhibitors. Trans-(4-aminomethyl
cyclohesanecarbonyl)-Tyr( O-Pic)-octylamide inhibited PL, PK, urokinase (UK
) and thrombin (TH) with IC50 values of 0.53, 30, 5.3 and >400 muM, respect
ively: Trans-(4-amino methylcyclohesanecarbonyl)-Tyr(O-2-Pyrim)-4-carboxyan
ilide inhibited PL, PK, UK and TH with IC50 values of 36, 0.56, 430 and >10
00 muM, respectively.